WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 2'6601 Infant (under 12 months) mortality rate: 622
GDP / capita (US$): 5'8671 Child (under 5 years) mortality rate: 962

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 4'448  4'337  4'225  4'112  3'995  3'126  2'383  1'796 
Births 167  165  162  159  155  122  91  76 
Surviving infants 156  154  151  148  144  112  84  70 
Pop. less than 5 years 738  722  703  682  664  514  394  321 
Pop. less than 15 years 1'892  1'842  1'791  1'736  1'689  1'310  1'041  804 
Female 15-49 years 1'049  1'024  1'001  977  949  744  541  395 

Number of reported case

(Click for retrospective incidence data for Congo (the))
Diphtheria
Japanese encephalitis
Measles 124  260  315  1'678  3'608  11'892 
Mumps
Pertussis 137  12  52  11'198 
Polio* 380  47  136 
Rubella 107  22  10  11 
Rubella (CRS)
Tetanus (neonatal) 18  80 
Tetanus (total) 27  167 
Yellow fever 188 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Congo (the))
Vaccine year result method % card seen                                                
BCG 2010  94  DHS   57  92  92  95  95  90  50  86 
DTP1 2010  89  DHS   57  90  90  90  90  93 
DTP3 2010  72  DHS   57  85  85  90  90  91  33  77 
HepB_BD         
HepB3 2010  20  DHS   57  85  85  90  90  91 
Hib3 2010  20  DHS   57  85  85  90  90  91 
JapEnc         
MCV 2010  75  DHS   57  80  80  90  90  76  34  77 
MCV2         
PCV1          90  50 
PCV3          85  10 
Pol3 2010  57  DHS   57  85  85  90  90  91  94 
Rota1         
Rota_last         
Rubella1         
TT2plus 2010  61  DHS   57  85  85  92  92  91  39  52 
PAB         
VAD1          86  77  90  90  86 
YFV 2010  55  DHS   57  80  80  90  90  77 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Congo (the))
BCG 92  92  95  95  90  50  90  92 
DTP1 90  90  90  90  92  45  92  67 
DTP3 69  69  74  74  78  33  79  42 
HepB3 69  69  74  74  75 
HepB_BD
Hib3 69  69  74  74  72 
MCV 65  65  75  75  63  34  75  49 
MCV2
PAB 83  83  83  83  82  67  60 
PnC3 69  10 
Pol3 67  67  72  72  76  31  80  42 
Rota_last
YFV 65  65  75  75  66 

Number of districts in the country 30  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 30
From 80 to 89% 43
From 50 to 79% 27
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 8, 12, 16 weeks; Yes
Measles 36 weeks; Yes
OPV birth; 8, 12, 16 weeks; Yes
Pneumo_conj 8, 12, 16 weeks; Yes
Rotavirus Yes From April 2014
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
VitaminA 36 weeks; Yes
YF 36 weeks; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2011-2015  2008-2011  2008-2011  2008-2011  2008 à 2011 
Nº of districts with microplans that include activities to raise immunization coverage number 30  30  30  30  30  27  27 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No       

System performance

Total Nº districts in country number 30  30  30  30  30  27  27 
Nº districts with DTP3 coverage >=80% number 22  21  22  19  24  24  13 
% of districts with DTP3 coverage >=80% From 0 to 100% 73  70  73  63  80  89  48 
Nº districts with measles (MCV1) coverage >=95% number  
% of districts with MCV1 coverage >=95% From 0 to 100% 10  13  23  13   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  No  No  No  No  No  No 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 15  11  NA  100  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.